PNC Financial Services Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $430K | Buy |
|
|||||
|
2025
Q2 | $280K | Buy |
|
|||||
|
2025
Q1 | $195K | Buy |
|
|||||
|
2024
Q4 | $171K | Buy |
|
|||||
|
2024
Q3 | $176K | Sell |
|
|||||
|
2024
Q2 | $235K | Buy |
|
|||||
|
2024
Q1 | $295K | Sell |
|
|||||
|
2023
Q4 | $337K | Sell |
|
|||||
|
2023
Q3 | $309K | Buy |
|
|||||
|
2023
Q2 | $147K | Buy |
|
|||||
|
2023
Q1 | $114K | Sell |
|
|||||
|
2022
Q4 | $115K | Sell |
|
|||||
|
2022
Q3 | $194K | Buy |
|
|||||
|
2022
Q2 | $172K | Sell |
|
|||||
|
2022
Q1 | $189K | Sell |
|
|||||
|
2021
Q4 | $960K | Sell |
|
|||||
|
2021
Q3 | $1.48M | Buy |
|
|||||
|
2021
Q2 | $2.1M | Sell |
|
|||||
|
2021
Q1 | $1.64M | Buy |
|
|||||
|
2020
Q4 | $1.93M | Buy |
|
|||||
|
2020
Q3 | $961K | Buy |
|
|||||
|
2020
Q2 | $798K | Sell |
|
|||||
|
2020
Q1 | $888K | Buy |
|
|||||
|
2019
Q4 | $1.25M | Sell |
|
|||||
|
2019
Q3 | $855K | Sell |
|
|||||
|
2019
Q2 | $1.02M | Hold |
|
|||||
|
2019
Q1 | $774K | Buy |
|
|||||
|
2018
Q4 | $616K | Buy |
|
|||||
|
2018
Q3 | $254K | Sell |
|
|||||
|
2018
Q2 | $581K | Buy |
|